Merck halts testing of experimental skin cancer combination therapy (NYSE:MRK)
merck (New York Stock Exchange: MRK) has discontinued the vibostolimab and pembrolizumab coformulation arm of a late-stage skin cancer trial. ...
merck (New York Stock Exchange: MRK) has discontinued the vibostolimab and pembrolizumab coformulation arm of a late-stage skin cancer trial. ...
Kameleon007/iStock via Getty Images New Phase 2 data showed that prostate cancer patients who received a Johnson & Johnson combination ...
koto_feja Bristol-Myers Squibb (New York Stock Exchange:BMY) has returned the rights to a preclinical cancer drug candidate, an SOS1 inhibitor, ...
© Reuters. LOS ANGELES - Puma Biotechnology, Inc. (NASDAQ: NASDAQ :) has begun a Phase II clinical trial to evaluate ...
News by Erik S. Lesser/Getty Images merck (New York Stock Exchange: MRK) announced detailed results from its Phase 3 AMBASSADOR ...
Awesome Games Done Quick (AGDQ) 2024 has concluded after a week-long non-stop speedrunning marathon. This year's charity raised more than ...
The first documented case of pancreatic cancer dates back to the 18th century. Since then, researchers have undertaken a long ...
Md Babul Hosen/iStock via Getty Images Shattuck Laboratories (NASDAQ: STTK) shares soared 90% in morning trading Wednesday after the biotech ...
The Web3 Metaverse super app, Plateaucontinues its partnership with the world's leading breast cancer organization, Susan G. Komen, to raise ...
VitaDAO, a decentralized autonomous organization (DAO) collective dedicated to early-stage longevity research, funded the launch of a biotechnology company, Matrix ...